Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $294.1b | $168.30 | +0.2% | 1.8M |
 TMO | Thermo Fisher Scientific, Inc. | $186.3b | $530.38 | -2.0% | 1.1M |
 DHR | Danaher Corporation | $134.8b | $204.22 | -0.6% | 3.9M |
 WAT | Waters Corp | $36.8b | $368.86 | -2.4% | 470.7K |
 GH | Guardant Health, Inc. Common Stock | $19.9b | $153.25 | +0.6% | 1.7M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $14.6b | $79.99 | +1.4% | 1.1M |
 RVTY | Revvity, Inc. | $12.4b | $110.13 | -1.4% | 1.0M |
 TECH | Bio-Techne Corp. | $11.0b | $71.70 | +0.5% | 2.5M |
 TEM | Tempus AI, Inc. Class A Common Stock | $10.4b | $52.45 | -2.1% | 3.4M |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $9.4b | $115.83 | +1.5% | 623.8K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $9.3b | $314.74 | +1.9% | 242.8K |
 LNTH | Lantheus Holdings, Inc | $7.2b | $107.50 | +2.3% | 884.9K |
 TWST | Twist Bioscience Corporation Common Stock | $6.4b | $93.97 | +2.9% | 1.0M |
 CAI | Caris Life Sciences, Inc. Common Stock | $5.0b | $16.73 | +0.0% | 2.8M |
 DYN | Dyne Therapeutics, Inc. Common Stock | $3.7b | $24.20 | +4.5% | 1.4M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.6b | $36.75 | +0.2% | 793.2K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $3.4b | $22.84 | +3.7% | 2.8M |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.0b | $62.76 | +3.0% | 456.8K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.7b | $28.82 | +3.5% | 279.7K |
 CDNA | CareDx, Inc. | $1.5b | $39.94 | -1.5% | 1.5M |
 ANRO | Alto Neuroscience Inc. | $0.9b | $27.53 | +0.8% | 692.8K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.7b | $6.97 | +1.3% | 302.8K |
 CSTL | Castle Biosciences, Inc. Common Stock | $0.7b | $24.11 | -0.4% | 198.3K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.6b | $4.65 | -0.1% | 552.7K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $487.8m | $19.39 | +2.9% | 311.3K |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $484.1m | $5.79 | +0.7% | 347.8K |
 PRLD | Prelude Therapeutics Incorporated | $424.5m | $4.20 | +0.7% | 146.0K |
 OABI | OmniAb, Inc. Common Stock | $356.6m | $2.13 | +4.4% | 443.3K |
 LAB | Standard BioTools Inc. Common Stock | $322.1m | $0.90 | +4.9% | 722.1K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $286.5m | $5.20 | +2.1% | 378.0K |
 ACIU | AC Immune SA | $242.2m | $2.25 | +0.5% | 343.9K |
 AVXL | Anavex Life Sciences | $240.0m | $2.43 | +2.1% | 1.8M |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $237.6m | $1.73 | +7.0% | 838.6K |
 BDSX | Biodesix, Inc. Common Stock | $233.5m | $20.65 | +0.2% | 37.6K |
 QTRX | Quanterix Corporation Common Stock | $203.5m | $3.88 | -2.3% | 497.2K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $192.7m | $0.82 | +0.5% | 2.2M |
 XGN | Exagen Inc. Common Stock | $112.3m | $4.43 | +3.6% | 153.6K |
 SEER | Seer, Inc. Class A Common Stock | $91.3m | $2.15 | +0.5% | 112.3K |
 IBIO | iBio, Inc. Common Stock | $86.9m | $1.41 | +2.6% | 572.7K |
 CSBR | Champions Oncology, Inc. | $85.5m | $6.13 | 0.0% | 11.6K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $76.2m | $1.77 | -0.3% | 236.1K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $71.3m | $2.05 | -7.3% | 18.8K |
 CCEL | Cryo-Cell International Inc. | $25.7m | $3.46 | -0.6% | 17.7K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $23.9m | $4.18 | 0.0% | 7.3K |
 MDXH | MDxHealth SA Ordinary Shares | $21.1m | $0.42 | -0.6% | 309.3K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $20.5m | $1.16 | +0.9% | 77.8K |
 ADVB | Advanced Biomed Inc. Common Stock | $7.7m | $6.38 | +5.9% | 10.2K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $6.5m | $1.75 | +2.4% | 14.5K |